Pendekatan Terapi Polycystic Ovary Syndrome (PCOS)
DOI:
https://doi.org/10.55175/cdk.v47i9.571Kata Kunci:
PCOS, Polycystic Ovary Syndrome, sistem endokrin, terapiAbstrak
Polycystic Ovary Syndrome (PCOS) juga dikenal sebagai hyperandrogenic anovulation (HA), merupakan kelainan sistem endokrin yang menyebabkan gangguan kesuburan wanita usia reproduktif. PCOS melibatkan ketidakseimbangan kadar luteinizing hormone (LH) dan follicle-stimulating hormone (FSH), resistensi insulin, dan kelainan metabolisme. Clomiphene citrate masih menjadi pilihan terapi utama untuk menstimulasi ovulasi pada kasus PCOS. Metformin juga menurunkan kadar androgen yang dapat meningkatkan terjadinya ovulasi spontan. Terapi lini kedua adalah gonadotropin dan bedah laparoskopi ovarium.
Polycystic Ovarian Syndrome (PCOS), also referred to as hyperandrogenic anovulation (HA), is an endocrine system disorders that affect women in their reproductive age. PCOS typically involves hormonal imbalances between luteinizing hormone (LH) and follicle-stimulating hormone (FSH), insulin resistance, and metabolic abnormalities. Clomiphene citrate (CC) is considered the first line treatment for ovulation induction in women with Polycystic Ovary Syndrome (PCOS). Metformin also decreases androgens in both lean and obese women, leading to increased rates of spontaneous ovulation. Second choice is gonadotropin and ovarian laparoscopy
Unduhan
Referensi
Abhishek S, Shivali S. Polycystic ovary syndrome: Pathogenesis, treatment and secondary associated diseases. J Drug Delivery and Therapeut. 2018;8(5):107-12
Londonkar RL, Hugar AL, Kanjikar AP. Polycystic ovary syndrome (PCOS)-A mini review. J Gynecol. 2018;2(1):000148.
Guang Hui-jan, Li Feng, Letrozole for all patients with polycystic ovarian syndrome: A retrospective study. Medicine 2018;97:44(e13038).
Qadr A, Adetunji H. Systematic review and meta-analysis of letrozole and clomiphen citrat in polycystic ovarian syndrome. Middle East Fertil Soc J. 2018;23:163-70.
Crasto W, Rao P. The effect of metformin on reproduction–A short review. J Endocrinol. Diabetes Obesity 2014;2(2):1038
Pasquali R. Contemporary approaches to the management of polycystic ovary syndrome. Therapeut Advances in Endocrinol Metabolism J. 2017;9(4):123 –34
Melo AS, FerrianiRA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome: Approach to clinical practice. Clinics 2015;70(11):765-9.
Jaganmohan C, Vannan M, Ali A, Parasuraman S. Evaluation of clinical efficacy of metformin therapy in polycystic ovary syndrome. J Young Pharm. 2017;9(2):277-9.
Hayek ES, Bitar L, Hamdar LH, Mirza FG, Daoud G. Polycystic ovarian syndrome: Update overview. Front Physiol. 2016;7:124.
Anadu NU. Polycystic ovary syndrome a review of treatment options with a focus on pharmacological approaches. Pharmacy and Therapeutic Journal.2013;38(6):336-55
Lee Tony T, Rausch Mary E. Polycystic ovarian syndrome: Role of imaging in diagnosis. RadioGraphics J. 2012;32:1643–57
Barbosa G, Rocha DRTW, Arbex A, de Sa LBPC. Polycystic ovary syndrome (PCOS) and fertility. J Endocrine and Metabolic Dis. 2016;06(01):58-65
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2020 https://creativecommons.org/licenses/by-nc/4.0/
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
